Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP64206.RAgzfoFw6JOApAy7nF-0AYhKbdIpwZ88-48oflu95UeOE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP64206.RAgzfoFw6JOApAy7nF-0AYhKbdIpwZ88-48oflu95UeOE130_assertion type Assertion NP64206.RAgzfoFw6JOApAy7nF-0AYhKbdIpwZ88-48oflu95UeOE130_head.
- NP64206.RAgzfoFw6JOApAy7nF-0AYhKbdIpwZ88-48oflu95UeOE130_assertion description "[In this pilot investigation, we found an increased prevalence of the CYP2C8*4 mutation in the Type 2 diabetic patient group. This may result in a modification of drug degradation and drug efficacy in these patients and may have an influence, e.g. on the choice of anti-diabetic drugs. However, further trials are necessary in order to confirm our findings.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP64206.RAgzfoFw6JOApAy7nF-0AYhKbdIpwZ88-48oflu95UeOE130_provenance.
- NP64206.RAgzfoFw6JOApAy7nF-0AYhKbdIpwZ88-48oflu95UeOE130_assertion evidence source_evidence_literature NP64206.RAgzfoFw6JOApAy7nF-0AYhKbdIpwZ88-48oflu95UeOE130_provenance.
- NP64206.RAgzfoFw6JOApAy7nF-0AYhKbdIpwZ88-48oflu95UeOE130_assertion SIO_000772 20857895 NP64206.RAgzfoFw6JOApAy7nF-0AYhKbdIpwZ88-48oflu95UeOE130_provenance.
- NP64206.RAgzfoFw6JOApAy7nF-0AYhKbdIpwZ88-48oflu95UeOE130_assertion wasDerivedFrom gad-20130706 NP64206.RAgzfoFw6JOApAy7nF-0AYhKbdIpwZ88-48oflu95UeOE130_provenance.
- NP64206.RAgzfoFw6JOApAy7nF-0AYhKbdIpwZ88-48oflu95UeOE130_assertion wasGeneratedBy ECO_0000203 NP64206.RAgzfoFw6JOApAy7nF-0AYhKbdIpwZ88-48oflu95UeOE130_provenance.